Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.43 USD | -6.95% | -7.76% | -36.57% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.57% | 199M | |
+6.33% | 217B | |
+11.79% | 190B | |
+18.68% | 143B | |
+29.85% | 111B | |
+0.65% | 64.59B | |
+14.86% | 52.36B | |
+2.06% | 48.45B | |
-5.22% | 38.03B | |
-0.83% | 35.6B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Earnings Flash (NPCE) NEUROPACE Reports Q2 Revenue $16.5M, vs. Street Est of $12.6M